Page 17 - 《中国药科大学学报》2026年第2期

第 57 卷第 2 期 伍 悦，等：细胞氧感受器 FIH 抑制剂的研究进展 143

pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoi- BO Rep, 2011, 12(5): 463-469.
etin secretagogues[J]. ACS Med Chem Lett, 2010, 1(9): 526- [42] Conejo-Garcia A, McDonough MA, Loenarz C, et al. Struc-
529. tural basis for binding of cyclic 2-oxoglutarate analogues to fac-
[26] Chowdhury R, McDonough MA, Mecinović J, et al. Structural tor-inhibiting hypoxia-inducible factor[J]. Bioorg Med Chem
basis for binding of hypoxia-inducible factor to the oxygen- Lett, 2010, 20(20): 6125-6128.
sensing prolyl hydroxylases[J]. Structure, 2009, 17(7): 981-989. [43] Moon H, Han S, Park H, et al. Crystal structures of human FIH-
[27] Iyer SR, Chaplin VD, Knapp MJ, et al. O 2 activation by non- 1 in complex with quinol family inhibitors[J]. Mol Cells, 2010,
II
heme Fe α-ketoglutarate-dependent enzyme variants: elucidat- 29(5): 471-474.
ing the role of the facial triad carboxylate in FIH[J]. J Am Chem [44] Hopkinson RJ, Tumber A, Yapp C, et al. 5-Carboxy-8-hydrox-
Soc, 2018, 140(37): 11777-11783. yquinoline is a broad spectrum 2-oxoglutarate oxygenase in-
[28] Tarhonskaya H, Chowdhury R, Leung IKH, et al. Investigating hibitor which causes iron translocation[J]. Chem Sci, 2013, 4(8):
the contribution of the active site environment to the slow reac- 3110-3117.
tion of hypoxia-inducible factor prolyl hydroxylase domain 2 [45] McAllister TE, England KS, Hopkinson RJ, et al. Recent
with oxygen[J]. Biochem J, 2014, 463(3): 363-372. progress in histone demethylase inhibitors[J]. J Med Chem,
[29] Flashman E, Hoffart LM, Hamed RB, et al. Evidence for the 2016, 59(4): 1308-1329.
slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 [46] Vachal P, Miao SW, Pierce JM, et al. 1, 3, 8-Triazaspiro [4.5]
with oxygen[J]. FEBS J, 2010, 277(19): 4089-4099. decane-2, 4-diones as efficacious pan-inhibitors of hypoxia-in-
[30] Domene C, Jorgensen C, Schofield CJ. Mechanism of molecu- ducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the
lar oxygen diffusion in a hypoxia-sensing prolyl hydroxylase treatment of Anemia[J]. J Med Chem, 2012, 55(7): 2945-2959.
using multiscale simulation[J]. J Am Chem Soc, 2020, 142(5): [47] McDonough MA, McNeill LA, Tilliet M, et al. Selective inhibi-
2253-2263. tion of factor inhibiting hypoxia-inducible factor[J]. J Am Chem
[31] Taabazuing CY, Fermann J, Garman S, et al. Substrate pro- Soc, 2005, 127(21): 7680-7681.
motes productive gas binding in the α-ketoglutarate-dependent [48] Corner TP, Teo RZR, Wu Y, et al. Structure-guided optimisa-
oxygenase FIH[J]. Biochemistry, 2016, 55(2): 277-286. tion of N-hydroxythiazole-derived inhibitors of factor inhibiting
[32] Tarhonskaya H, Hardy AP, Howe EA, et al. Kinetic investiga- hypoxia-inducible factor-α[J]. Chem Sci, 2023, 14(43): 12098-
tions of the role of factor inhibiting hypoxia-inducible factor 12120.
(FIH) as an oxygen sensor[J]. J Biol Chem, 2015, 290(32): [49] Martin CB, Taabazuing CY, Knapp MJ. Dynamic domain links
19726-19742. substrate binding and catalysis in the factor-inhibiting-HIF-1[J].
[33] Loenarz C, Mecinović J, Chowdhury R, et al. Evidence for a Biochemistry, 2023, 62(16): 2442-2449.
stereoelectronic effect in human oxygen sensing[J]. Angew [50] Nakashima Y, Brewitz L, Tumber A, et al. 2-Oxoglutarate
Chem Int Ed, 2009, 48(10): 1784-1787. derivatives can selectively enhance or inhibit the activity of hu-
[34] Chaplin VD, Valliere MA, Hangasky JA, et al. Investigations man oxygenases[J]. Nat Commun, 2021, 12(1): 6478.
on the role of a solvent tunnel in the α-ketoglutarate dependent [51] Wu Y, Jiang ZS, Li ZH, et al. Click chemistry-based discovery
oxygenase factor inhibiting HIF (FIH)[J]. J Inorg Biochem, of [3-hydroxy-5-(1 H-1, 2, 3-triazol-4-yl)picolinoyl] glycines as
2018, 178: 63-69. orally active hypoxia-inducing factor prolyl hydroxylase in-
[35] Hewitson KS, Liénard BMR, McDonough MA, et al. Structural hibitors with favorable safety profiles for the treatment of Ane-
and mechanistic studies on the inhibition of the hypoxia-in- mia[J]. J Med Chem, 2018, 61(12): 5332-5349.
ducible transcription factor hydroxylases by tricarboxylic acid [52] Li ZH, Zhen S, Su KJ, et al. A small-molecule probe for moni-
cycle intermediates[J]. J Biol Chem, 2007, 282(5): 3293-3301. toring binding to prolyl hydroxylase domain 2 by fluorescence
[36] Yang M, Chowdhury R, Ge W, et al. Factor-inhibiting hypoxia- polarisation[J]. Chem Commun, 2020, 56(91): 14199-14202.
inducible factor (FIH) catalyses the post-translational hydroxy- [53] Li ZH, Wu Y, Zhen S, et al. In situ inhibitor synthesis and
lation of histidinyl residues within ankyrin repeat domains[J]. screening by fluorescence polarization: an efficient approach for
FEBS J, 2011, 278(7): 1086-1097. accelerating drug discovery[J]. Angew Chem Weinheim Bergstr
[37] Zhang N, Fu ZX, Linke S, et al. The asparaginyl hydroxylase Ger, 2022, 134(45): e202211510.
factor inhibiting HIF-1alpha is an essential regulator of [54] Wu Y, Chen YF, Corner TP, et al. A small-molecule inhibitor
metabolism[J]. Cell Metab, 2010, 11(5): 364-378. of factor inhibiting HIF binding to a tyrosine-flip pocket for the
[38] Sim J, Cowburn AS, Palazon A, et al. The factor inhibiting HIF treatment of obesity[J]. Angew Chem Int Ed, 2024, 63(40):
asparaginyl hydroxylase regulates oxidative metabolism and ac- e202410438.
celerates metabolic adaptation to hypoxia[J]. Cell Metab, 2018, [55] Wu Y, Zhang ZW, Cai HP, et al. Discovery of ZG-2305, an
27(4): 898-913. e7. orally bioavailable factor inhibiting HIF inhibitor for the treat-
[39] Yeh TL, Leissing TM, Abboud MI, et al. Molecular and cellu- ment of obesity and fatty liver disease[J]. J Med Chem, 2025,
lar mechanisms of HIF prolyl hydroxylase inhibitors in clinical 68(1): 212-235.
trials[J]. Chem Sci, 2017, 8(11): 7651-7668. [56] Hu H, Hu W, Guo AD, et al. Spatiotemporal and direct captur-
[40] Loenarz C, Coleman ML, Boleininger A, et al. The hypoxia-in- ing global substrates of lysine-modifying enzymes in living
ducible transcription factor pathway regulates oxygen sensing in cells[J]. Nat Commun, 2024, 15(1): 1465.
the simplest animal, Trichoplax adhaerens[J]. EMBO Rep, [57] Wu Y, Li ZH, Kaur S, et al. Light-induced, lysine-targeting irre-
2011, 12(1): 63-70. versible covalent inhibition of the human oxygen sensing hy-
[41] Chowdhury R, Yeoh KK, Tian YM, et al. The oncometabolite droxylase factor inhibiting HIF (FIH)[J]. J Am Chem Soc, 2025,
2-hydroxyglutarate inhibits histone lysine demethylases[J]. EM- 147(21): 17871-17879.